- AVNR has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $134.3 million.
- AVNR has traded 1.4 million shares today.
- AVNR is down 9.4% today.
- AVNR was up 85.3% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in AVNR with the Ticky from Trade-Ideas. See the FREE profile for AVNR NOW at Trade-Ideas More details on AVNR: Avanir Pharmaceuticals, Inc., together with its subsidiaries, is engaged in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States. Currently there are 2 analysts that rate AVANIR Pharmaceuticals a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for AVANIR Pharmaceuticals has been 2.1 million shares per day over the past 30 days. AVANIR has a market cap of $1.2 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.78 and a short float of 11.7% with 1.37 days to cover. Shares are up 100.6% year-to-date as of the close of trading on Friday.